Yazan Alsayed

5.5k total citations
61 papers, 3.1k citations indexed

About

Yazan Alsayed is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Yazan Alsayed has authored 61 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 39 papers in Hematology and 24 papers in Oncology. Recurrent topics in Yazan Alsayed's work include Multiple Myeloma Research and Treatments (37 papers), Protein Degradation and Inhibitors (24 papers) and Cytokine Signaling Pathways and Interactions (9 papers). Yazan Alsayed is often cited by papers focused on Multiple Myeloma Research and Treatments (37 papers), Protein Degradation and Inhibitors (24 papers) and Cytokine Signaling Pathways and Interactions (9 papers). Yazan Alsayed collaborates with scholars based in United States, Canada and Japan. Yazan Alsayed's co-authors include Bart Barlogie, John Crowley, Frits van Rhee, Leonidas C. Platanias, Elias Anaissie, John D. Shaughnessy, Sarah Waheed, Shahab Uddin, Bijay Nair and Antje Hoering and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Yazan Alsayed

58 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yazan Alsayed United States 29 2.2k 1.9k 1.5k 529 309 61 3.1k
Harald Herrmann Austria 27 2.1k 0.9× 1.4k 0.7× 647 0.4× 610 1.2× 533 1.7× 72 3.3k
Kensuke Kojima Japan 29 1.8k 0.8× 959 0.5× 1.1k 0.7× 327 0.6× 444 1.4× 135 2.9k
Renate Burger Germany 27 1.6k 0.7× 990 0.5× 1.1k 0.8× 628 1.2× 221 0.7× 66 2.9k
Catherine Pellat‐Deceunynck France 36 1.9k 0.9× 1.5k 0.8× 1.2k 0.9× 1.3k 2.4× 523 1.7× 98 3.7k
Thomas Kindler Germany 27 1.5k 0.7× 1.7k 0.9× 615 0.4× 342 0.6× 768 2.5× 78 3.0k
Virginie Penard‐Lacronique France 23 1.4k 0.6× 977 0.5× 829 0.6× 573 1.1× 592 1.9× 44 2.8k
Maria Antonia Frassanito Italy 30 1.3k 0.6× 1.0k 0.5× 738 0.5× 723 1.4× 138 0.4× 68 2.5k
Masayuki Towatari Japan 27 1.7k 0.8× 1.6k 0.8× 570 0.4× 433 0.8× 595 1.9× 40 2.9k
Sylvie Freeman United Kingdom 27 1.5k 0.7× 2.0k 1.0× 535 0.4× 840 1.6× 490 1.6× 73 3.3k
Fumihiko Hayakawa Japan 26 1.4k 0.6× 1.1k 0.6× 624 0.4× 303 0.6× 430 1.4× 85 2.4k

Countries citing papers authored by Yazan Alsayed

Since Specialization
Citations

This map shows the geographic impact of Yazan Alsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yazan Alsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yazan Alsayed more than expected).

Fields of papers citing papers by Yazan Alsayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yazan Alsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yazan Alsayed. The network helps show where Yazan Alsayed may publish in the future.

Co-authorship network of co-authors of Yazan Alsayed

This figure shows the co-authorship network connecting the top 25 collaborators of Yazan Alsayed. A scholar is included among the top collaborators of Yazan Alsayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yazan Alsayed. Yazan Alsayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heuck, Christoph, Jackie Szymonifka, John D. Shaughnessy, et al.. (2012). Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene NR3C1. Clinical Cancer Research. 18(19). 5499–5506. 13 indexed citations
2.
Usmani, Saad Z., John Crowley, Antje Hoering, et al.. (2012). Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?. Leukemia. 27(1). 226–232. 71 indexed citations
3.
Usmani, Saad Z., Bijay Nair, Pingping Qu, et al.. (2012). Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols. Leukemia. 26(11). 2398–2405. 45 indexed citations
4.
Usmani, Saad Z., Christoph Heuck, Alyson E. Mitchell, et al.. (2012). Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents. Haematologica. 97(11). 1761–1767. 270 indexed citations
5.
Shaughnessy, John D., Pingping Qu, Saad Z. Usmani, et al.. (2011). Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3. Blood. 118(13). 3512–3524. 127 indexed citations
6.
Waheed, Sarah, John D. Shaughnessy, Frits van Rhee, et al.. (2010). International staging system and metaphase cytogenetic abnormalities in the era of gene expression profiling data in multiple myeloma treated with total therapy 2 and 3 protocols. Cancer. 117(5). 1001–1009. 22 indexed citations
7.
8.
Shaughnessy, John D., Yiming Zhou, Jeff Haessler, et al.. (2009). TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3. British Journal of Haematology. 147(3). 347–351. 50 indexed citations
9.
Barlogie, Bart, Elias Anaissie, Jeffrey Haessler, et al.. (2008). Complete remission sustained 3 years from treatment initiation is a powerful surrogate for extended survival in multiple myeloma. Cancer. 113(2). 355–359. 90 indexed citations
10.
Haessler, Jeffrey, John D. Shaughnessy, Fenghuang Zhan, et al.. (2007). Benefit of Complete Response in Multiple Myeloma Limited to High-Risk Subgroup Identified by Gene Expression Profiling. Clinical Cancer Research. 13(23). 7073–7079. 75 indexed citations
11.
Shaughnessy, John D., Jeffrey Haessler, Frits van Rhee, et al.. (2007). Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics. British Journal of Haematology. 137(6). 530–536. 38 indexed citations
12.
Khalil, Haitham, et al.. (2007). Sentinel Lymph Node Biopsy (SLNB) in management of N0 stage T1–T2 lip cancer as a “Same Day” procedure. Oral Oncology. 44(6). 608–612. 21 indexed citations
13.
Alsayed, Yazan, Shahab Uddin, Nadim Mahmud, et al.. (2001). Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to All-trans-retinoic Acid. Journal of Biological Chemistry. 276(6). 4012–4019. 145 indexed citations
14.
Alsayed, Yazan, Shahab Uddin, Sarfraz Ahmad, et al.. (2000). IFN-γ Activates the C3G/Rap1 Signaling Pathway. The Journal of Immunology. 164(4). 1800–1806. 58 indexed citations
15.
Alsayed, Yazan, Sanjiv Modi, Shahab Uddin, et al.. (2000). All-trans-retinoic acid induces tyrosine phosphorylation of the CrkL adapter in acute promyelocytic leukemia cells. Experimental Hematology. 28(7). 826–832. 8 indexed citations
16.
Du, Jianbin, et al.. (2000). Engagement of the CrkL Adapter in Interleukin-5 Signaling in Eosinophils. Journal of Biological Chemistry. 275(42). 33167–33175. 25 indexed citations
17.
Wickrema, Amittha, Shahab Uddin, Arun K. Sharma, et al.. (1999). Engagement of Gab1 and Gab2 in Erythropoietin Signaling. Journal of Biological Chemistry. 274(35). 24469–24474. 89 indexed citations
18.
Uddin, Shahab, Beata Majchrzak, Yazan Alsayed, et al.. (1999). Activation of the p38 Mitogen-activated Protein Kinase by Type I Interferons. Journal of Biological Chemistry. 274(42). 30127–30131. 205 indexed citations
19.
Uddin, Shahab, Dorie A. Sher, Yazan Alsayed, et al.. (1997). Interaction of p59fynwith Interferon-Activated Jak Kinases. Biochemical and Biophysical Research Communications. 235(1). 83–88. 40 indexed citations
20.
Ahmad, Sarfraz, Yazan Alsayed, Brian Druker, & Leonidas C. Platanias. (1997). The Type I Interferon Receptor Mediates Tyrosine Phosphorylation of the CrkL Adaptor Protein. Journal of Biological Chemistry. 272(48). 29991–29994. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harald Herrmann Breakdown of academic impact, for papers by Kensuke Kojima Breakdown of academic impact, for papers by Renate Burger Breakdown of academic impact, for papers by Catherine Pellat‐Deceunynck Breakdown of academic impact, for papers by Thomas Kindler Breakdown of academic impact, for papers by Virginie Penard‐Lacronique Breakdown of academic impact, for papers by Maria Antonia Frassanito Breakdown of academic impact, for papers by Masayuki Towatari Breakdown of academic impact, for papers by Sylvie Freeman Breakdown of academic impact, for papers by Fumihiko Hayakawa
Rankless by CCL
2026